African Journal of Biotechnology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

 

Afr. J. Biotechnol.


Vol. 4 No. 1
3



Viewing options:


 • Abstract
 • Full text
 • Reprint (PDF) (117K)

Search Pubmed for articles by:

 

Zeba B

 


Other links:


PubMed Citation


Related articles in PubMed

 

African Journal of Biotechnology Vol. 4 (13), pp. 1559-1562, Special Review 2005          
ISSN 1684–5315 © 2005 Academic Journals

 

 

Review

 

Overview of b-lactamase incidence on bacterial drug resistance

 

Boukaré ZEBA

 

UFR-SVT/ Université de Ouagadougou/ Burkina Faso, 03 Bp 7021 Ouagadougou 03. E-mail: aboubakrzeba@yahoo.fr.

 

Accepted 15 September, 2005

 

 
    Abstract

 

 

The bacterial drug resistance is its ability to grow in presence of high  concentration of an antibiotic. The massive and often unsuitable use of antibiotic tends to select the resistant mutants that are then disseminated. The β-lactam antibiotics represent an antibiotic family widely used because of their remarkable tolerance by animal organism. This practice generated the resistance from many bacteria in clinical and environmental spaces. One of the main drug resistance mechanism used by bacteria is the production of inactivation enzymes named β-lactamases. This mini review attempts to pinpoint the β-lactamase incidence on the failure of clinical treatment using  β-lactam antibiotic anywhere.

 

Key words: Bacteria, β-lactamase, drug resistance.

 

 


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Copyright © 2005 by Academic Journals.